Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Active tracked intramyocardial catheter injections for regenerative therapy with real-time MR guidance: feasibility in the porcine heart.
Tseng CCS, Wenker S, Bakker MH, Kraaijeveld AO, Dankers PYW, Seevinck PR, Smink J, Kimmel S, van Slochteren FJ, Chamuleau SAJ. Tseng CCS, et al. Among authors: wenker s. EuroIntervention. 2019 Jul 20;15(4):e336-e339. doi: 10.4244/EIJ-D-17-01081. EuroIntervention. 2019. PMID: 30082260 Free article. No abstract available.
Publication rate in preclinical research: a plea for preregistration.
van der Naald M, Wenker S, Doevendans PA, Wever KE, Chamuleau SAJ. van der Naald M, et al. Among authors: wenker s. BMJ Open Sci. 2020 Aug 27;4(1):e100051. doi: 10.1136/bmjos-2019-100051. eCollection 2020. BMJ Open Sci. 2020. PMID: 35047690 Free PMC article.
Neutral Effects of Combined Treatment With GLP-1R Agonist Exenatide and MR Antagonist Potassium Canrenoate on Cardiac Function in Porcine and Murine Chronic Heart Failure Models.
Demkes EJ, Wenker S, Silvis MJM, van Nieuwburg MMJ, Visser MJ, Jansen MS, Brans MAD, Velema E, Sluijter JPG, Hoefer IE, de Kleijn DPV, Timmers L, de Jager SCA. Demkes EJ, et al. Among authors: wenker s. Front Pharmacol. 2021 Jul 26;12:702326. doi: 10.3389/fphar.2021.702326. eCollection 2021. Front Pharmacol. 2021. PMID: 34381364 Free PMC article.
Do immunosuppressive treatments influence immune responses against adenovirus-based COVID-19 vaccines in patients with multiple sclerosis? An Argentine multicenter study.
Silva BA, Miglietta E, Casabona JC, Wenker S, Eizaguirre MB, Alonso R, Casas M, Lázaro LG, Man F, Portuondo G, Lopez Bisso A, Zavala N, Casales F, Imhoff G, Steinberg DJ, López PA, Carnero Contentti E, Deri N, Sinay V, Hryb J, Chiganer E, Leguizamon F, Tkachuk V, Bauer J, Ferrandina F, Giachello S, Henestroza P, Garcea O, Pascuale CA, Heitrich M, Podhajcer OL, Vinzón S, D'Alotto-Moreno T, Benatar A, Rabinovich GA, Pitossi FJ, Ferrari CC. Silva BA, et al. Among authors: wenker s. Front Immunol. 2024 Aug 19;15:1431403. doi: 10.3389/fimmu.2024.1431403. eCollection 2024. Front Immunol. 2024. PMID: 39224589 Free PMC article.
Humoral response and neutralising capacity at 6 months post-vaccination against COVID-19 among institutionalised older adults in Argentina.
Rodriguez PE, Silva AP, Miglietta EA, Rall P, Pascuale CA, Ballejo C, López Miranda L, Ríos AS, Ramis L, Marro J, Poncet V, Mazzitelli B, Salvatori M, Ceballos A, Gonzalez Lopez Ledesma MM, Ojeda DS, Aguirre MF, Miragaya Y, Gamarnik AV, Rossi AH; Laboratorio SeVa Group; PAMI Group. Rodriguez PE, et al. Front Immunol. 2022 Sep 26;13:992370. doi: 10.3389/fimmu.2022.992370. eCollection 2022. Front Immunol. 2022. PMID: 36225925 Free PMC article.
25 results